Patents Assigned to Seres Therapeutics, Inc.
  • COMPOSITIONS AND METHODS
    Publication number: 20210244774
    Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
    Type: Application
    Filed: April 5, 2021
    Publication date: August 12, 2021
    Applicant: Seres Therapeutics, Inc,
    Inventors: Gregory MCKENZIE, Mary-Jane LOMBARDO MCKENZIE, David N. COOK, Marin VULIC, Geoffrey VON MALTZAHN, Brian GOODMAN, John Grant AUNINS, Matthew R. HENN, David Arthur BERRY, Jonathan WINKLER
  • DESIGNED BACTERIAL COMPOSITIONS AND USES THEREOF
    Publication number: 20210196766
    Abstract: Our client, Seres Therapeutics, has asked us to file a new provisional application related to bacterial compositions and the use of such compositions for the treatment of inflammatory bowel disease.
    Type: Application
    Filed: May 24, 2019
    Publication date: July 1, 2021
    Applicant: Seres Therapeutics, Inc.
    Inventors: Asuncion MARTINEZ, Edward J. O'BRIEN, Sheri Lynn SIMMONS, David COOK, Matthew R. HENN, Christopher B. FORD, Divya BALASUBRAMANIAN, Ambar PIÑA, Liyang DIAO, Meghan CHAFEE, Marin VULIC, Madhumitha NANDAKUMAR, Sumon DATTA, Latta JAYARAMAN
  • Synergistic Bacterial Compositions and Methods of Production and Use Thereof
    Publication number: 20210169949
    Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 10, 2021
    Applicant: Seres Therapeutics, Inc,
    Inventors: Matthew R. HENN, Geoffrey von MALTZAHN, Anthony Mario D'ONOFRIO, Kevin Daniel LITCOFSKY, David Arthur BERRY, David N. COOK, Noubar B. AFEYAN, John Grant AUNINS
  • Synergistic Bacterial Compositions and Methods of Production and Use Thereof
    Publication number: 20210169947
    Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 10, 2021
    Applicant: Seres Therapeutics, Inc,
    Inventors: Matthew R. HENN, Geoffrey von MALTZAHN, Anthony Mario D'ONOFRIO, Kevin Daniel LITCOFSKY, David Arthur BERRY, David N. COOK, Noubar B. AFEYAN, John Grant AUNINS
  • Synergistic Bacterial Compositions and Methods of Production and Use Thereof
    Publication number: 20210169948
    Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 10, 2021
    Applicant: Seres Therapeutics, Inc,
    Inventors: Matthew R. HENN, Geoffrey von MALTZAHN, Anthony Mario D'ONOFRIO, Kevin Daniel LITCOFSKY, David Arthur BERRY, David N. COOK, Noubar B. AFEYAN, John Grant AUNINS
  • Synergistic Bacterial Compositions and Methods of Production and Use Thereof
    Publication number: 20210169946
    Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 10, 2021
    Applicant: Seres Therapeutics, Inc,
    Inventors: Matthew R. HENN, Geoffrey von MALTZAHN, Anthony Mario D'ONOFRIO, Kevin Daniel LITCOFSKY, David Arthur BERRY, David N. COOK, Noubar B. AFEYAN, John Grant AUNINS
  • COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES
    Publication number: 20210121505
    Abstract: Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with an inflammatory bowel disease.
    Type: Application
    Filed: March 29, 2019
    Publication date: April 29, 2021
    Applicant: Seres Therapeutics, Inc.
    Inventors: Madhumitha NANDAKUMAR, Edward J. O'BRIEN, Sumon DATTA
  • Compositions and methods
    Patent number: 10973861
    Abstract: Provided are defined bacterial compositions for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for populating the gastrointestinal tract of a subject. Provided also are bacterial formulations for oral or gastric administration to a mammalian subject in an effective amount for prevention or treatment of a gastrointestinal disease, disorder or condition.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: April 13, 2021
    Assignee: Seres Therapeutics, Inc.
    Inventors: Noubar B. Afeyan, Mary-Jane Lombardo McKenzie, Kevin Daniel Litcofsky, David N. Cook, Matthew R. Henn, Geoffrey von Maltzahn
  • Compositions and methods
    Patent number: 10967011
    Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: April 6, 2021
    Assignee: Seres Therapeutics, Inc.
    Inventors: Gregory McKenzie, Mary-Jane Lombardo McKenzie, David N. Cook, Marin Vulic, Geoffrey von Maltzahn, Brian Goodman, John Grant Aunins, Matthew R. Henn, David Arthur Berry, Jonathan Winkler
  • COMPOSITIONS AND METHODS FOR TREATING CHOLESTATIC DISEASE
    Publication number: 20210008128
    Abstract: The invention provides compositions and methods for use in the treatment and prevention of cholestatic diseases.
    Type: Application
    Filed: August 14, 2018
    Publication date: January 14, 2021
    Applicant: Seres Therapeutics, Inc.
    Inventors: Madhumitha NANDAKUMAR, Alice Peiyu LIOU, Elizabeth Moritz HALVORSEN, Gregory MCKENZIE, Edward J. O'BRIEN, David COOK
  • Network-based microbial compositions and methods
    Patent number: 10881696
    Abstract: Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: January 5, 2021
    Assignee: Seres Therapeutics, Inc.
    Inventors: Matthew R. Henn, David N. Cook, Toshiro K. Ohsumi, Mary-Jane Lombardo McKenzie, Kevin D. Litcofsky, Han Zhang, John Grant Aunins, David Arthur Berry
  • Synergistic bacterial compositions and methods of production and use thereof
    Patent number: 10864235
    Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: December 15, 2020
    Assignee: Seres Therapeutics, Inc.
    Inventors: Matthew R. Henn, Geoffrey von Maltzahn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook, Noubar B. Afeyan, John Grant Aunins
  • COMPOSITIONS AND METHODS FOR TREATING ANTIBIOTIC RESISTANCE
    Publication number: 20200353018
    Abstract: The present invention relates to compositions and methods for reducing the carriage of antibiotic resistance genes.
    Type: Application
    Filed: October 30, 2018
    Publication date: November 12, 2020
    Applicant: Seres Therapeutics, Inc.
    Inventors: Christopher Burton FORD, Jessica BRYANT, Edward J. O'BRIEN
  • Synergistic Bacterial Compositions and Methods of Production and Use Thereof
    Publication number: 20200345792
    Abstract: Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Application
    Filed: December 21, 2018
    Publication date: November 5, 2020
    Applicant: SERES THERAPEUTICS, INC.
    Inventors: Matthew R. Henn, Kevin Daniel Litcofsky, Anthony Mario D'Onofrio, Toshiro K. Ohsumi, Mary-Jane Lombardo McKenzie, Geoffrey von Maltzahn, David N. Cook, David Arthur Berry, Noubar B. Afeyan, John Grant Aunins
  • MANIPULATION OF TRYPTAMINE METABOLISM
    Publication number: 20200276249
    Abstract: Compositions and methods for altering tryptamine levels in a subject are provided. In general, the compositions comprise microorganisms.
    Type: Application
    Filed: October 3, 2018
    Publication date: September 3, 2020
    Applicant: Seres Therapeutics, Inc.
    Inventors: Edward J. O'BRIEN, Asuncion MARTINEZ
  • Synergistic Bacterial Compositions and Methods of Production and Use Thereof
    Publication number: 20190350988
    Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Application
    Filed: December 17, 2018
    Publication date: November 21, 2019
    Applicant: Seres Therapeutics, Inc.
    Inventors: Matthew R. Henn, Geoffrey von Maltzahn, Anthony Mario D'Onofrio, Kevin Daniel Litcofsky, David Arthur Berry, David N. Cook, Noubar B. Afeyan, John Grant Aunins
  • Synergistic bacterial compositions and methods of production and use thereof
    Patent number: 10258655
    Abstract: Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: April 16, 2019
    Assignee: Seres Therapeutics, Inc.
    Inventors: Matthew R. Henn, Kevin Daniel Litcofsky, Anthony Mario D'Onofrio, Toshiro K. Ohsumi, Mary-Jane Lombardo McKenzie, Geoffrey von Maltzahn, David N. Cook, David Arthur Berry, Noubar B. Afeyan, John Grant Aunins
  • Network-based microbial compositions and methods
    Patent number: 10076546
    Abstract: Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: September 18, 2018
    Assignee: Seres Therapeutics, Inc.
    Inventors: Matthew R. Henn, David N. Cook, Toshiro K. Ohsumi, Mary-Jane Lombardo McKenzie, Kevin D. Litcofsky, Han Zhang, John Grant Aunins, David Berry
  • Methods of populating a gastrointestinal tract
    Patent number: 10064900
    Abstract: Methods and compositions for populating the gastrointestinal tract of a subject are described. Methods include administering to a subject a therapeutic composition comprising a purified population of spore-forming bacteria produced by providing a fecal material and subjecting the material to a treatment step resulting in purification of spore-forming bacteria. Methods include administering an amount effective to engraft and/or augment in the gastrointestinal tract in order to treat or prevent a dysbiosis in the mammalian subject.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: September 4, 2018
    Assignee: Seres Therapeutics, Inc.
    Inventors: Geoffrey Von Maltzahn, Matthew R. Henn, David N. Cook, David Arthur Berry, Noubar B. Afeyan, Brian Goodman, Mary-Jane Lombardo McKenzie, Marin Vulic
  • Compositions and methods
    Patent number: 10064901
    Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: September 4, 2018
    Assignee: Seres Therapeutics, Inc.
    Inventors: Gregory McKenzie, Mary-Jane Lombardo McKenzie, David N. Cook, Marin Vulic, Geoffrey von Maltzahn, Brian Goodman, John Grant Aunins, Matthew R. Henn, David Arthur Berry, Jonathan Winkler